The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective randomized phase II trial to assess the efficacy and safety of neo-adjuvant olaparib/carboplatin (OC) in comparison to docetaxel/epirubicin/cyclophosphamide (TAC) in patients with early triple-negative breast cancer (TNBC) with homologous recombination deficiency (HRD): Primary results from the ABCSG 45 trial.
 
Christian Singer
Honoraria - AstraZeneca/MedImmune; Daiichi Sankyo Europe GmbH; Novartis
Consulting or Advisory Role - AstraZeneca/MedImmune; Daiichi-Sanyko; Gilead Sciences; Novartis; Sanofi/Aventis
Speakers' Bureau - AstraZeneca/MedImmune; Novartis
Research Funding - Amgen; Amgen; AstraZeneca/MedImmune; Myriad Genetics; Novartis; Roche; Sanofi
Travel, Accommodations, Expenses - Daiichi-Sankyo; Gilead Sciences; Novartis; Roche
 
Dominik Hlauschek
Research Funding - Amgen (Inst); Amgen (Inst); Artera (Inst); AstraZeneca (Inst); Ataraxis (Inst); Berlin Chemie AG (Inst); Bristol Myers Squibb (Inst); Cepheid (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Natera (Inst); Novartis (Inst); OncoMark (Inst); Pfizer (Inst); Roche (Inst); Sandoz (Inst)
 
Daniel Egle
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; Menarini Group; Novartis; Pfizer; Roche/Genentech; Sirius Medical
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; Menarini Group; MSD; Novartis; Roche/Genentech
Research Funding - Sirius Medical (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Menarini Group; Pfizer
 
Zsuzsanna Bago-Horvath
Honoraria - AstraZeneca/UK; Gilead Sciences; MSD; Stemline Therapeutics
Consulting or Advisory Role - Abbvie; AstraZeneca/UK; Gilead Sciences; Stemline Therapeutics
Research Funding - Roche
Expert Testimony - AstraZeneca/UK; Stemline Therapeutics
 
Georg Pfeiler
Honoraria - Accord Healthcare; Amgen; AstraZeneca/Daiichi Sankyo; AstraZeneca/Merck; Gilead Sciences; Lilly; Menarini Group; Novartis; Pfizer; Roche/Genentech; Seagen; UCB
Consulting or Advisory Role - Amgen; AstraZeneca/Daiichi Sankyo; AstraZeneca/Merck; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Seagen; UCB
Speakers' Bureau - Accord Healthcare; Amgen; AstraZeneca/Daiichi Sankyo; AstraZeneca/Merck; Gilead Sciences; Lilly; Novartis; Pfizer; Roche/Genentech; Seagen; UCB
Research Funding - Accord Healthcare; AstraZeneca (Inst); Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Accord Research; AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; Lilly; Merck; Novartis; Pfizer; Roche/Genentech; Seagen
 
Christine Brunner
Employment - Roche
Honoraria - Amgen; Daiichi Sankyo/Astra Zeneca; Novartis Institutes for BioMedical Research; Roche
Consulting or Advisory Role - Roche
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo/Astra Zeneca; Roche
 
Christian Peters-Engl
No Relationships to Disclose
 
Edgar Petru
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Roche
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Roche
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Roche
 
Daniel Reimer
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; PharmaMar
Research Funding - AstraZeneca
Other Relationship - MSD
 
Renate Pusch
Consulting or Advisory Role - Novartis; Roche; Stemline Therapeutics
 
Michael Seifert
Speakers' Bureau - MSD
Travel, Accommodations, Expenses - Pfizer
 
Petra Pichler
Travel, Accommodations, Expenses - BeiGene; Gilead Sciences; Roche
 
Christoph Suppan
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Pierre Fabre
 
Annette Reiner
Stock and Other Ownership Interests - BioNTech (I); Pfizer (I)
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Richard Greil
Stock and Other Ownership Interests - Lilly (Inst); Novo Nordisk (Inst)
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Merck; MSD; Novartis; Roche; Sandoz; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; Merck; MSD; Novartis; Roche; Sanofi; Takeda
Research Funding - Abbvie; Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen-Cilag; MSD; Novartis; Roche
 
Yen Tan
Research Funding - Pfizer
Travel, Accommodations, Expenses - SOPHiA Genetics
 
Rupert Bartsch
Honoraria - AstraZeneca; Daiicho; Lilly; Novartis; Pfizer; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi; Eisai; Lilly; MSD Oncology; MSD Oncology; Novartis; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Puma Biotechnology; Roche; Seagen
Research Funding - Daiichi (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Pfizer; Pfizer; Roche; Roche
 
Katharina Knoll
No Relationships to Disclose
 
Anna Kermanidis
Research Funding - AstraZeneca (Inst)
 
Michael Gnant
Employment - Sandoz (I)
Honoraria - Amgen; AstraZeneca; Daiichi Sankyo Europe GmbH; EPG Health; Lilly; Menarini; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Bayer; Daiichi-Sankyo; Lilly; Menarini; MSD Oncology; Novartis; Veracyte
Expert Testimony - Lilly; Veracyte
Travel, Accommodations, Expenses - Lilly; Stemline Therapeutics
Other Relationship - ABCSG GmbH; ABCSG Research Services GmbH